Epidemiology of Diabetes

Journal of Clinical Pharmacology

Volumn 44, Issue 4, 2004, Pages 397-405

  Winer, Nathaniel ^a   Sowers, James R ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Health care; Morbidity; Mortality; Obesity; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

AGING; AMPUTATION; BLINDNESS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; DIETARY INTAKE; DYSLIPIDEMIA; EXERCISE; HEALTH CARE DISTRIBUTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; INDUSTRIALIZATION; KIDNEY FAILURE; LIFESTYLE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR; SITTING; UNITED STATES; VASCULAR DISEASE;

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; HEALTH CARE COSTS; HUMANS; PREVALENCE;

EID: 1642344350     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270004263017     Document Type: Conference Paper

References (83)

1. Anderson RN: Deaths: leading causes for 2000. Natl Vital Stat Rep 2002;16:1-85.
2. Geiss LS, Herman WH, Smith PJ: Mortality in non-insulin-dependent diabetes, in: National Diabetes Data Group: Diabetes in America. 2nd ed., NIH pub. no. 95-1468. Washington, DC: Government Printing Office, 1995;233-257.
3. Harris MI: Summary, in: National Diabetes Data Group: Diabetes in America. 2nd ed., NIH pub. no. 95-1468. Washington, DC: Government Printing Office, 1995;1-14.
4. International Diabetes Federation Task Force on Diabetes Health Economics: Facts, Figures and Forecasts. Brussels: International Diabetes Federation, 1997.
5. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates and projections. Diabetes Care 1998;21:1414-1431.
6. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, et al: Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001;24:1936-1940.
7. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, et al: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21(4):475-476.
8. Pan XR, Li GW, Hu YH, Wang JX, An ZX, et al: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20: 537-544.
9. Tuomilheto J, Lindstrom J, Eriksson JG, et al: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
10. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6): 393-403.
11. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed diabetic individuals: does the clock start ticking before the onset of clinical diabetes? JAMA 1990; 263:2893-2898.
12. Harris MI, Robbins DC: Prevalence of adult-onset diabetes in the U.S. population. Diabetes Care 1995;18:885-886.
13. Fagot-Gampagna A, Narayan K: Type 2 diabetes in children. Br Med J 2001;322:377-387.
14. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P: Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996;128(5, Pt. 1):608-615.
15. Kitagawa T, Owada M, Urakami T, Tajima N: Epidemiology of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in Japanese children. Diabetes Res Clin Pract 1994;24(Suppl.):S7-S13.
16. Dabelea D, Hanson RI, Bennett PH, Roumain J, Knowler WC, Pettit DJ: Increasing prevalence of type 2 diabetes in American Indian children. Diabetologia 1998;41:904-910.
17. Scott CR, Smith JM, Craddock MM, Pihocker C: Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics 1997;100(1):84-89.
18. Neufeld ND, Raffel LJ, Landon C, Chen YD, Vadheim CM: Early presentation of type 2 diabetes in Mexican-American youth. Diabetes Care 1998;21:80-86.
19. Zimmet P, Alberti KGMM, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001;13:782-787.
20. Ogden CL, Flegal KM, Carroll MD, Johnson CL: Prevalence and trends in overweight among US children and adolescents. 1999-2000. JAMA 2002;288:1728-1732.
21. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288;1772-1773.
22. Shafrir E: Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes Metab 1997; 22:131-148.
23. Neel J: Diabetes mellitus: a "thrifty genotype" rendered detrimental by "progress"? Am J Hum Genet 1962;14:353-362.
24. Hales CN, Barker DJP: Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992;35: 595-601.
25. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE Study Group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of diagnostic criteria in Europe. Lancet 1999;354:617-621.
26. Kuusisto J, Mykkaanen L, Pyorala K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994;43:960-967.
27. Khaw K-T, Wareham N, Luben R, Bingham S, Oakes S, Welch A, et al: Glycated haemoglobin, diabetes and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). Br Med J 2001;322:15-18.
28. Haffner SM: The insulin resistance syndrome revisited. Diabetes Care 1996;19:275-277.
29. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS): prospective observational study. Br Med J 2000;321:405-412.
30. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-957.
31. Garg A, Grudy SM: Management of dyslipidemias in NIDDM. Diabetes Care 1990;13:153-169.
32. Meigs JB: Epidemiology of the metabolic syndrome. Am J Manag Care 2002;8(11, Suppl 1.):S283-S292.
33. McFarlane SI, Banerji M, Sowers JR: Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001;86:713-718.
34. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
35. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
36. Fujimoto WY, Bergstrom RW, Leonetti DL, Newell-Morris LL, Shuman WP, Wahl PW: Metabolic and adipose risk factors for NIDDM and coronary disease in third-generation Japanese-American men and women with impaired glucose tolerance. Diabetologia 1994;37: 524-532.
37. Ahima RS, Flier JS: Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000;11:327-332.
38. Gastaldelli A, Miyazaki Y, Pettiti M, Matsuda M, Mahankali S, Santini E, et al: Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 2002;87:5098-5103.
39. Boden G, Chen X: Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 1995;96:1261-1268.
40. Bujalska IJ, Kumar S, Stewart PM: Does central obesity reflect "Cushing's disease of the omentum"? Lancet 1997;349:1210-1213.
41. Pradhan AD, Manson JE, Rifai N, et al: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334.
42. Barzilay JI, Abraham L, Heckbert SR, et al: The relationship of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001;50:2384-2389.
43. Tan TS, Sattar N, Williams K, Gonzalez-Villapando C, Lean ME, Haffner SM: Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002;25:2016-2021.
44. Festa A, D'Agostino RJ, Howard G, et al: Chronic subclinical inflammation as part of insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;103:42-47.
45. Ruiz-ortega M, Lorenzo O, Suzuki Y, et al: Proinflammatory actions of angiotensins. Curr Opin Neprol Hypertns 2001;10;329:321-329.
46. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-153.
47. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al: Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002;359:995-1003.
48. Morgan CL, Currie CJ, Peters JR: Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care 2000;23:211.
49. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multirole Risk Factor Intervention Trial. Diabetes Care 1993; 16:434-444.
50. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, et al: A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151(6):1141-1147.
51. Sprafka JM, Burke GL, Folsom AR, McGovern PG, Hahn LP: Trends in the prevalence of diabetes mellitus in patients with myocardial infarction and effects of diabetes on survival. The Minnesota Heart Survey. Diabetes Care 1991;14:537-543.
52. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemala M, Haffner SM, et al: Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998;21(1):69-75.
53. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without myocardial infarction. N Engl J Med 1998;339:229-234.
54. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, et al: Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000;102:1014-1019.
55. Goraya TY, Leibson CL, Palumbo PJ, Weston SA, Killian JM, Pfeiffer EA, et al: Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 2002;40(5):946-953.
56. Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB: The impact of diabetes and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 2002;40(5):954-960.
57. Laskey WK, Selzer F, Vlachos HA, Johnston J, Jacobs A, King SB, et al: Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 2002;90:1062-1067.
58. Szabo Z, Hakanson E, Svedjeholm R: Early postoperative morbidity and medium term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thor Surg 2002;74(3):712-719.
59. Solang L, Malmberg K, Ryden L: Diabetes mellitus and congestive heart failure; further knowledge needed. Eur Heart J 1999;20:789-795.
60. Davis RC, Hobbs FD, Kenkre JE, Roalfe AK, Hare R, Lancashire RJ, et al: Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiologic study. Br Med J 2002;325(7373):1156.
61. Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, et al: Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Function (SOLVD) Trials and Registry. Am J Cardiol 1996;77(11):1017-1020.
62. Poirier P, Garneau C, Marois L, Bogaty P, Dumesnil J-G: Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for pre-clinical diabetic cardiomyopathy. Diabetes Care 2001;24:5-10.
63. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, et al: Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 2001;32:280-289.
64. Lindgarth B, Hillborn N: Associations between brain infarction, diabetes and alcoholism: observations from the Gothenburg population cohort study. Acta Neurol Scan 1987;75:195-200.
65. Lackland DT, Moore MA: Hypertension-related mortality and morbidity in the Southeast. South Med J 1997;90:191-198.
66. Burchfiel CM, Curb JD, Rodriguez BL, Abbot RM, Chiu D, Yano K: Glucose intolerance and the 22-year stroke incidence: the Honolulu Heart Program. Stroke 1994;25:951-957.
67. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979;241:2035-2038.
68. Sacco RL: Reducing the risk of stroke in diabetes: what we have learned that is new? Diabetes Obes Metab 2002;4(Suppl 1):S27-S34.
69. Kagan A, Popper JS, Rhoads GG: Factors related to stroke incidence in Hawaii in Japanese men. Stroke 1980;12:14-21.
70. Webster P: The natural history of stroke in diabetic patients. Acta Med Scand 1980;207:417-424.
71. Gray CS, Taylor R, French JM, Alberti KM, Venables GS, James OF, et al: The prognostic value of stress hyperglycemia and previously unrecognized diabetes in acute stroke. Diabetes Med 1987;4:237-240.
72. Davis TM, Millns H, Stratton IM, Holman RR, Turner RC: Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med 1999;159:1033-1034.
73. Stegmayr B, Asplund K: Diabetes as a risk factor for stroke: a population perspective. Diabetologia 1995;38:1061-1068.
74. Morley J, Marichak R, Rials SJ, Kowey P: Atrial fibrillation, anticoagulation and stroke. Am J Cardiol 1996;77:38A-44A.
75. Bell DS: Stroke in the diabetic patient. Diabetes Care 1994;17: 2123-2219.
76. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. Br Med J 1998;317:703-713.
77. Curb JD, Pressel SL, Cutler J, Savage PJ, Applegate WB, Black H, et al: Effect of diuretic-based antihypertensive treatment on cardiovascular risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program. JAMA 1996; 276:1886-1892.
78. Birkenhager WH, Staessen JA, Gasowski L, de leeuw PW: Effect of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (SYST-EUR) trial. J Nephrol 2000;13:232-237.
79. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-259.
80. Sowers JR, Epstein M, Frolich ED: Diabetes, hypertension and cardiovascular disease: an update. Hypertension 2001;37:1053-1059.
81. Meittinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 1996;27:2033-2039.
82. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS: Urine albumin excretion: an independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999;19(8): 1992-1997.
83. Gerstein HC, Mann JFE, Yi O, Zinman B, Dinnean SF, Hoogwef B, et al: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286(4): 421-426.